Mice bearing CXorf56-knockdown MDA-MB-231 cells displayed more noticeable tumor shrinkage in the olaparib-treated group; this difference was eliminated with Ku70- knockdown (Fig. 5I–K). Here, STEEP1 is linked to neoplasm.